Hui Miao

Director/Board Member presso Beijing Zhendong Langdi Pharmaceutical Co., Ltd.

49 anni

Health Technology

Consumer Services

Profilo

Hui Miao is currently the Director at Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Prior to this, Mr. Miao served as the President, Chief Executive Officer & Director at GuangYuYuan Chinese Herbal Medicine Co., Ltd.
from 2022 to 2024.
Mr. Miao completed their undergraduate degree at Renmin University of China.

Posizioni attive di Hui Miao

Società	Posizione	Inizio
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The private company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003.	Director/Board Member	-

Tutte le posizioni attive di Hui Miao

Precedenti posizioni note di Hui Miao

Società	Posizione	Fine
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	Chief Executive Officer	09/04/2024

Vedi nel dettaglio l'esperienza di Hui Miao

Formazione di Hui Miao

Renmin University of China

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Hui Miao

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	Health Technology

Aziende private	1
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The private company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003.	Health Technology